Creatine supplementation and resistance training to preserve muscle mass and attenuate cancer progression (CREATINE-52): A protocol for a double-blind randomized controlled trial

Muscle mass is important for metastatic prostate cancer survival and quality of life (QoL). The backbone of treatment for men with metastatic castration sensitive prostate cancer (mCSPC) is androgen deprivation therapy (ADT) with an androgen signaling inhibitor.